Anne M. Phillips

CIK: 0001627680

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)5 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)1 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

BRNS

Barinthus Biotherapeutics plc.

Director

VTVT

vTv Therapeutics Inc.

Director

SGMT

Sagimet Biosciences Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

BRNS
Barinthus Biotherapeutics plc.
Sep 9, 2026
Disposition(D)
Direct
3K shares-
VTVT
vTv Therapeutics Inc.
Jun 26, 2026
Award(A)
Director stock option (right to buy)
Direct
6K shares at avg. $35.08-
SGMT
Sagimet Biosciences Inc.
Jun 12, 2026
Award(A)
Stock Option (Right to Buy)
Direct
39.6K shares-
VTVT
vTv Therapeutics Inc.
Jun 10, 2025
Award(A)
Director stock option (right to buy)
Direct
4K shares at avg. $16.59-
BRNS
Barinthus Biotherapeutics plc.
Jun 10, 2025
Award(A)
Share Option (Right to Buy)
Direct
20.2K shares-
SGMT
Sagimet Biosciences Inc.
Jun 9, 2025
Award(A)
Stock Option (Right to Buy)
Direct
27.3K shares-

		Type	Shares	Price		Ownership
Sep 9, 2026	BRNS Barinthus Biotherapeutics plc.	Disposition(D)	3,000	-	$0	Direct
Jun 26, 2026	VTVT vTv Therapeutics Inc.	Award(A) Director stock option (right to buy)	6,000	$35.08	-	Direct
Jun 12, 2026	SGMT Sagimet Biosciences Inc.	Award(A) Stock Option (Right to Buy)	39,567	-	-	Direct
Jun 10, 2025	VTVT vTv Therapeutics Inc.	Award(A) Director stock option (right to buy)	4,000	$16.59	-	Direct
Jun 10, 2025	BRNS Barinthus Biotherapeutics plc.	Award(A) Share Option (Right to Buy)	20,174	-	-	Direct
Jun 9, 2025	SGMT Sagimet Biosciences Inc.	Award(A) Stock Option (Right to Buy)	27,268	-	-	Direct

1-6 of 6 transactions

About Phillips Anne M.

Phillips Anne M. (SEC CIK 0001627680) files insider reports with the SEC as Director of Barinthus Biotherapeutics plc. (BRNS), Director of vTv Therapeutics Inc. (VTVT) and Director of Sagimet Biosciences Inc. (SGMT).

Signal8 holds 6 ownership filings by Phillips Anne M., all Form 4s, filed between Jun 10, 2025 and Sep 9, 2026. Those filings report 6 transactions, from Jun 9, 2025 to Sep 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Phillips Anne M.'s filings is in GERMANTOWN, MD.

Recent filings by Phillips Anne M.

Sep 9, 2026: Disposition to issuer transaction of BRNS shares (Form 4, code D).
Jun 26, 2026: Grant or award of VTVT derivative securities (Form 4, code A).
Jun 12, 2026: Grant or award of SGMT derivative securities (Form 4, code A).
Jun 10, 2025: Grant or award of VTVT derivative securities (Form 4, code A).
Jun 10, 2025: Grant or award of BRNS derivative securities (Form 4, code A).

Other insiders filing for Barinthus Biotherapeutics plc. (BRNS)

Oxford Science Enterprises plc, Officer
Wright Robin, Director
Scheeren Joseph, Director
Morgon Pierre A., Director
Hooftman Leon, Chief Medical Officer
Hammacher Alex, Director

How to read Form 4 transaction codes